FR2924946B1 - Utilisation cosmetique de proteines de type ceramidase acide - Google Patents

Utilisation cosmetique de proteines de type ceramidase acide

Info

Publication number
FR2924946B1
FR2924946B1 FR0759929A FR0759929A FR2924946B1 FR 2924946 B1 FR2924946 B1 FR 2924946B1 FR 0759929 A FR0759929 A FR 0759929A FR 0759929 A FR0759929 A FR 0759929A FR 2924946 B1 FR2924946 B1 FR 2924946B1
Authority
FR
France
Prior art keywords
proteins
cosmetic use
acid ceramidase
ceramidase
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0759929A
Other languages
English (en)
Other versions
FR2924946A1 (fr
Inventor
Dominique Bernard
Lucie Simonetti
Isabelle Castiel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0759929A priority Critical patent/FR2924946B1/fr
Priority to PCT/IB2008/055423 priority patent/WO2009077995A1/fr
Priority to US12/809,428 priority patent/US20110091439A1/en
Priority to EP08861250A priority patent/EP2224902A1/fr
Publication of FR2924946A1 publication Critical patent/FR2924946A1/fr
Application granted granted Critical
Publication of FR2924946B1 publication Critical patent/FR2924946B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
FR0759929A 2007-12-18 2007-12-18 Utilisation cosmetique de proteines de type ceramidase acide Expired - Fee Related FR2924946B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0759929A FR2924946B1 (fr) 2007-12-18 2007-12-18 Utilisation cosmetique de proteines de type ceramidase acide
PCT/IB2008/055423 WO2009077995A1 (fr) 2007-12-18 2008-12-18 Utilisation cosmétique de protéines de type céramidase acide
US12/809,428 US20110091439A1 (en) 2007-12-18 2008-12-18 Cosmetic use of acid ceramidase type proteins
EP08861250A EP2224902A1 (fr) 2007-12-18 2008-12-18 Utilisation cosmétique de protéines de type céramidase acide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0759929A FR2924946B1 (fr) 2007-12-18 2007-12-18 Utilisation cosmetique de proteines de type ceramidase acide

Publications (2)

Publication Number Publication Date
FR2924946A1 FR2924946A1 (fr) 2009-06-19
FR2924946B1 true FR2924946B1 (fr) 2010-02-26

Family

ID=39616578

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0759929A Expired - Fee Related FR2924946B1 (fr) 2007-12-18 2007-12-18 Utilisation cosmetique de proteines de type ceramidase acide

Country Status (4)

Country Link
US (1) US20110091439A1 (fr)
EP (1) EP2224902A1 (fr)
FR (1) FR2924946B1 (fr)
WO (1) WO2009077995A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006007560A2 (fr) 2004-07-01 2006-01-19 University Of Pennsylvania Remplacement de proteines ciblees pour le traitement de maladies lysosomales
WO2011069913A1 (fr) * 2009-12-07 2011-06-16 Chanel Parfums Beaute Procédé pour cribler des agents actifs qui stimulent l'expression de cert pour améliorer la fonction de barrière de la peau
WO2011087525A1 (fr) 2010-01-17 2011-07-21 The Procter & Gamble Company Procedes a base de biomarqueurs pour formuler des compositions qui ameliorent la qualite de la peau et reduisent les signes visibles du vieillissement de la peau chez des individus d'une population selectionnee
CA2800537C (fr) 2010-06-11 2016-02-09 The Procter & Gamble Company Compositions pour traitement de la peau
EP2618808B1 (fr) * 2010-09-24 2016-09-21 L'Oréal Utilisation cosmétique de la dermcidine ou fragments de celle-ci
FR2965358B1 (fr) * 2010-09-24 2014-10-10 Oreal Utilisation cosmetique de la dermcidine, analogues ou fragments de celle-ci
FR2965357B1 (fr) * 2010-09-24 2014-10-03 Oreal Utilisation cosmetique de la dermcidine, analogues ou fragments de celle-ci
US9671410B2 (en) 2011-01-16 2017-06-06 The Procter & Gamble Company Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin
HUE051021T2 (hu) 2011-09-07 2021-01-28 Sinai School Medicine Ceramidáz és sejtek differenciálódása
EP3679923B1 (fr) 2012-06-01 2021-08-04 Icahn School of Medicine at Mount Sinai Niveaux de céramide dans le traitement et la prévention d'infections
HUE046113T2 (hu) 2013-03-14 2020-02-28 Icahn School Med Mount Sinai Terápiás sav ceramidáz készítmények és azok elõállítási és felhasználási eljárásai
US10966916B2 (en) 2014-11-10 2021-04-06 The Procter And Gamble Company Personal care compositions
US11207248B2 (en) 2014-11-10 2021-12-28 The Procter And Gamble Company Personal care compositions with two benefit phases
WO2016077327A1 (fr) 2014-11-10 2016-05-19 The Procter & Gamble Company Compositions de soins personnels comportant deux phases à effet bénéfique
CN107148263B (zh) 2014-11-10 2021-07-06 宝洁公司 个人护理组合物
WO2019079405A1 (fr) 2017-10-20 2019-04-25 The Procter & Gamble Company Nettoyant moussant en aérosol pour la peau
EP3697375B1 (fr) 2017-10-20 2021-12-01 The Procter & Gamble Company Nettoyant pour la peau en mousse aérosol
WO2019113035A1 (fr) 2017-12-08 2019-06-13 The Procter & Gamble Company Procédés de criblage pour nettoyant doux pour la peau
WO2020112486A1 (fr) 2018-11-29 2020-06-04 The Procter & Gamble Company Méthodes de criblage de produits de soins personnels

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH062661B2 (ja) * 1986-12-22 1994-01-12 鐘紡株式会社 皮膚化粧料
JPH0426606A (ja) * 1990-05-23 1992-01-29 Kanebo Ltd 皮膚化粧料
AU679818B2 (en) * 1993-11-10 1997-07-10 Sloan-Kettering Institute For Cancer Research Butyric ester cyto-differentiating agents
AU2001240552A1 (en) * 2000-01-27 2001-08-07 Memorec Stoffel GmbH - Medizinisch - Molekulare Entwicklung, Koln Ceramidase
US6703204B1 (en) * 2000-07-28 2004-03-09 The Brigham & Women's Hospital, Inc. Prognostic classification of breast cancer through determination of nucleic acid sequence expression
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
EP1287815A1 (fr) * 2001-08-31 2003-03-05 Cosmoferm B.V. Utilisation d'une base sphingoide pour inhiber l'activité de la céramidase
FR2858932B1 (fr) * 2003-08-22 2009-10-30 Oreal Composition destinee a lutter contre la degradation des fibres de collagene induite en condition d'exposition solaire naturelle

Also Published As

Publication number Publication date
US20110091439A1 (en) 2011-04-21
FR2924946A1 (fr) 2009-06-19
EP2224902A1 (fr) 2010-09-08
WO2009077995A1 (fr) 2009-06-25

Similar Documents

Publication Publication Date Title
FR2924946B1 (fr) Utilisation cosmetique de proteines de type ceramidase acide
FR2925312B1 (fr) Utilisation cosmetique de proteines de type desmogleine i
FR2917629B1 (fr) Utilisation cosmetique de proteines de type apolipoproteine d
BRPI0811637A2 (pt) Proteínas de fusão da imunoglobina
BRPI0813105A2 (pt) Derivado de sulfonamida de ácido malônico e uso faramacêutico do mesmo
SMT201500081B (it) Composizione cosmetica acquosa comprendente alchilcellulosa
BR112012004546A2 (pt) "terapêutica por proteínas ligantes dll4-ligantes"
BRPI0915825A2 (pt) proteínas de ligação à prostaglandina e2 usos das mesmas
BRPI0914155A2 (pt) preparações de xampu
BRPI0810863A2 (pt) Uso de hidrolisados de proteína para estabilizar formulações de detergente de metaloprotease.
DK3118221T3 (da) Proteiner
DK2254908T3 (da) Kosmetiske eller farmaceutiske sammensætninger omfattende metalloproteinasehæmmere
FR2944435B1 (fr) Composition cosmetique comprenant de l'oridonine
FR2924613B1 (fr) Utilisation cosmetique de proteines de type hsp27.
BR112013009589A2 (pt) composição de cuidados com o cabelo
FR2924947B1 (fr) Utilisation cosmetique de proteines de type calmodulin-like skin protein clsp
BRPI0811016A2 (pt) Proteína li truncada do papiloma vírus humano tipo 16
FR2933868B1 (fr) Compositions cosmetiques
BRPI0914152A2 (pt) preparações de xampu
FR2925314B1 (fr) Utilisation cosmetique de proteines de type transglutaminase 3
BRPI0921947A2 (pt) formulações de proteína terapêutica
BRPI1014159A2 (pt) cosmético capilar
FR2924614B1 (fr) Utilisation cosmetique de proteines de type calgranuline a.
DK2307543T3 (da) Forbedret proteinekspressionssystem
BR112012025270A2 (pt) "composição de cuidados pessoais"

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

ST Notification of lapse

Effective date: 20170831